UPDATE: Massachusetts & Federal Agencies Recommend Pausing J&J Vaccines Due To Blood Clots

Share, email, print, bookmark SOURCE reports.

WASHINGTON DC – The Centers for Disease Control and Prevention and the Food and Drug Administration in a joint statement today, April 13, said the two federal agencies are investigating clots in six women that occurred 6 to 13 days after vaccination, and are recommending pausing the Johnson & Johnson one-shot COVID-19 vaccine.

The clots were observed in the sinuses of the brain along with reduced platelet counts — making the usual treatment for blood clots, the blood thinner heparin, potentially “dangerous.”

Due to the investigation, there is a recommendation to “pause” the administration of the single-dose Johnson & Johnson COVID-19 vaccine.

Massachusetts’ Department of Public Health announced this morning, April 13, it is pausing administration of the Johnson & Johnson COVID-19 vaccine following the federal recommendation.

In 2021, more than 6.8 million doses of the J&J vaccine have been administered in the U.S.

Most individuals have experience none or mild side effects with the vaccine.

There are two other COVID-19 vaccines available Moderna and Pfizer, but both require two shots.


email: editor@FraminghamSource.com call or text at 508-315-7176